Diabetic macular oedema: a prospective randomised trial of management with intravitreal bevacizumab (Avastin) versus conventional laser therapy in diabetic macula oedema.

Trial Profile

Diabetic macular oedema: a prospective randomised trial of management with intravitreal bevacizumab (Avastin) versus conventional laser therapy in diabetic macula oedema.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Acronyms BOLT
  • Most Recent Events

    • 01 Aug 2012 2-Year results published in the Archives of Ophthalmology (Report 3).
    • 05 Jan 2009 Status is completed, as reported by ISRCTN: Current Controlled Trials.
    • 13 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top